| Profile | GDS1873 / 203510_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 260.221 | 61 |
| GSM40788 | control - Rep 2 | 128.371 | 39 |
| GSM40789 | control - Rep 3 | 243.861 | 59 |
| GSM40775 | androgen treated - Rep 1 | 316.632 | 67 |
| GSM40776 | androgen treated - Rep 2 | 327.878 | 67 |
| GSM40777 | androgen treated - Rep 3 | 441.099 | 75 |
| GSM40790 | estrogen treated - Rep 1 | 288.318 | 64 |
| GSM40791 | estrogen treated - Rep 2 | 813.96 | 85 |
| GSM40792 | estrogen treated - Rep 3 | 368.385 | 70 |
| GSM40784 | A + tamoxifen - Rep 1 | 325.701 | 67 |
| GSM40785 | A + tamoxifen - Rep 2 | 363.333 | 70 |
| GSM40786 | A + tamoxifen - Rep 3 | 233.544 | 58 |
| GSM40778 | A + anastrozole - Rep 1 | 370.438 | 72 |
| GSM40779 | A + anastrozole - Rep 2 | 509.483 | 76 |
| GSM40780 | A + anastrozole - Rep 3 | 184.059 | 51 |
| GSM40781 | A + letrozole - Rep 1 | 216.931 | 56 |
| GSM40782 | A + letrozole - Rep 2 | 242.131 | 59 |
| GSM40783 | A + letrozole - Rep 3 | 262.143 | 62 |